{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:26:37Z","timestamp":1792499197157,"version":"4.5.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Yuquan Pill (YQW) is a modern concentrated pill preparation of six herbs, namely, Ge Gen (<jats:italic>Pueraria lobata<\/jats:italic> Ohwi), Di huang (<jats:italic>Rehmannia glutinosa<\/jats:italic> Libosch.), Tian Huafen (<jats:italic>Trichosanthes kirilowii<\/jats:italic> Maxim.), Mai Dong (<jats:italic>Ophiopogon japonicus<\/jats:italic> (L. f.) Ker Gawl.), Wu Weizi (<jats:italic>Schisandra chinensis<\/jats:italic> (Turcz.) Baill.) and Gan Cao (<jats:italic>Glycyrrhiza uralensis<\/jats:italic> Fisch.). It is extensively used to treat type 2 diabetes-related glucose and lipid metabolism disorders. But what\u2019s the pharmacodynamic substance and how it works in the treatment of Type 2 diabetes mellitus (T2DM) are still unclear.<\/jats:p><jats:p><jats:bold>Purpose:<\/jats:bold> The purpose of this study is to determine the likely pharmacological components and molecular mechanism of YQW\u2019s intervention on T2DM by combining serum pharmacochemistry, network analysis and transcriptomics.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The efficacy and prototypical components of blood entry were determined after oral administration of YQW aqueous solution to T2DM rats induced by high-fat feed and low-dose streptozotocin (STZ), and the key targets and pathways for these compounds to intervene in T2DM rats were predicted and integrated using network analysis and transcriptomics techniques.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In diabetic rats, YQW can lower TG, CHO, NO, and MDA levels (<jats:italic>p<\/jats:italic> &amp;lt; 0.05) while increasing HDL-C levels (<jats:italic>p<\/jats:italic> &amp;lt; 0.01), and protecting the liver and kidney. 22 prototype components (including puerarin, daidzein, 3\u2032-methoxypuerarin, and liquiritigenin, among others) were found in the serum of rats after oral administration of YQW for 90\u00a0min, which might be used as a possible important ingredient for YQW to intervene in T2DM rats. 538 YQW pharmacodynamic components-related targets and 1,667 disease-related targets were projected through the PharmMapper database, with 217 common targets between the two, all of which were engaged in regulating PI3K-Akt, MAPK, Ras and FoxO signal pathway. Finally, the mRNA expression profiles of liver tissues from rats in the control, model, and YQW groups were investigated using high-throughput mRNA sequencing technology. YQW can regulate the abnormal expression of 89 differential genes in a disease state, including 28 genes with abnormally high expression and 61 genes with abnormally low expression. Five common genes (Kit, Ppard, Ppara, Fabp4, and Tymp) and two extensively used regulatory pathways (PI3K-Akt and MAPK signaling pathways) were revealed by the integrated transcriptomics and network analysis study.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The mechanism of YQW\u2019s intervention in T2DM rats could be linked to 22 important components like puerarin, daidzein, and glycyrrhetinic acid further activating PI3K-Akt and MAPK signaling pathways by regulating key targets Kit, Ppard, Ppara, Fabp4, and Tymp, and thus improving lipid metabolism disorder, oxidative stress, and inflammation levels in T2DM rats. On the topic, more research into the pharmacological ingredient foundation and mechanism of YQW intervention in T2DM rats can be done.<\/jats:p>","DOI":"10.3389\/fphar.2023.1282077","type":"journal-article","created":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T10:05:02Z","timestamp":1700301902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Elucidating the pharmacodynamic mechanisms of Yuquan pill in T2DM rats through comprehensive multi-omics analyses"],"prefix":"10.3389","volume":"14","author":[{"given":"Yan","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongshui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"173758","DOI":"10.1016\/j.ejphar.2020.173758","article-title":"FoxO1 signaling as a therapeutic target for type 2 diabetes and obesity","volume":"891","author":"Benchoula","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jdiacomp.2015.07.008","article-title":"Metabolic syndrome and risk of major coronary events among the urban diabetic patients: north Indian Diabetes and Cardiovascular Disease Study-NIDCVD-2","volume":"30","author":"Bhatti","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"B3","doi-asserted-by":"publisher","first-page":"102944","DOI":"10.1016\/j.isci.2021.102944","article-title":"Role of hypothalamic MAPK\/ERK signaling and central action of FGF1 in diabetes remission","volume":"24","author":"Brown","year":"2021","journal-title":"iScience"},{"key":"B4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jep.2016.01.037","article-title":"Ophiopogon japonicus--A phytochemical, ethnomedicinal and pharmacological review","volume":"181","author":"Chen","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"109617","DOI":"10.1016\/j.cbi.2021.109617","article-title":"Dapagliflozin attenuates diabetic cardiomyopathy through erythropoietin up-regulation of AKT\/JAK\/MAPK pathways in streptozotocin-induced diabetic rats","volume":"347","author":"El-Sayed","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"B6","doi-asserted-by":"publisher","first-page":"k2234","DOI":"10.1136\/bmj.k2234","article-title":"Dietary and nutritional approaches for prevention and management of type 2 diabetes","volume":"361","author":"Forouhi","year":"2018","journal-title":"BMJ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B8","doi-asserted-by":"publisher","first-page":"108570","DOI":"10.1016\/j.biopha.2019.01.031","article-title":"Puerarin alleviates streptozotocin (STZ)-induced osteoporosis in rats through suppressing inflammation and apoptosis via HDAC1\/HDAC3 signaling","volume":"115","author":"Guo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.phymed.2016.04.008","article-title":"Reversal of diabetes-induced behavioral and neurochemical deficits by cinnamaldehyde","volume":"23","author":"Jawale","year":"2016","journal-title":"Phytomedicine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejphar.2008.12.057","article-title":"Antihyperglycemic effect of 18 beta-glycyrrhetinic acid, aglycone of glycyrrhizin, on streptozotocin-diabetic rats","volume":"606","author":"Kalaiarasi","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1161\/ATVBAHA.116.307302","article-title":"Impact of diabetes mellitus","volume":"36","author":"Kanter","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2147\/DMSO.S278928","article-title":"Consensus on medical nutrition therapy for diabesity (CoMeND) in adults: a south asian perspective","volume":"14","author":"Kapoor","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.tcb.2012.11.008","article-title":"Epigenetic flexibility in metabolic regulation: disease cause and prevention?","volume":"23","author":"Kirchner","year":"2013","journal-title":"Trends Cell Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"114820","DOI":"10.1016\/j.jep.2021.114820","article-title":"A systematic review on botany, processing, application, phytochemistry and pharmacological action of Radix Rehmnniae","volume":"285","author":"Li","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"bbab542","DOI":"10.1093\/bib\/bbab542","article-title":"TMNP: a transcriptome-based multi-scale network pharmacology platform for herbal medicine","volume":"23","author":"Li","year":"","journal-title":"Brief. Bioinform"},{"key":"B16","doi-asserted-by":"publisher","first-page":"106185","DOI":"10.1016\/j.phrs.2022.106185","article-title":"LTM-TCM: a comprehensive database for the linking of Traditional Chinese Medicine with modern medicine at molecular and phenotypic levels","volume":"178","author":"Li","year":"","journal-title":"Pharmacol. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0130550","DOI":"10.1371\/journal.pone.0130550","article-title":"The efficacy and safety of Chinese herbal medicine jinlida as add-on medication in type 2 diabetes patients ineffectively managed by Metformin monotherapy: a double-blind, randomized, placebo-controlled, multicenter trial","volume":"10","author":"Lian","year":"2015","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2022.111408","article-title":"Mechanism of glycometabolism regulation by bioactive compounds from the fruits of Lycium barbarum: a review","volume":"111408","author":"Liu","year":"2022","journal-title":"Food Res. Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"113558","DOI":"10.1016\/j.jep.2020.113558","article-title":"The treatment of asthma using the Chinese Materia Medica","volume":"269","author":"Liu","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"114999","DOI":"10.1016\/j.jep.2022.114999","article-title":"Xiaoyao Powder in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"288","author":"Liu","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2019.02.038","article-title":"A Chinese medicine formula (Jinqi Jiangtang Tablet): a review on its chemical constituents, quality control, pharmacokinetics studies, pharmacological properties and clinical applications","volume":"236","author":"Liu","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.amjms.2019.07.003","article-title":"Continuous glucose monitoring: review of an innovation in diabetes management","volume":"358","author":"Mian","year":"2019","journal-title":"Am. J. Med. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.fshw.2022.04.004","article-title":"Recent advances in the managements of type 2 diabetes mellitus and natural hypoglycemic substances","volume":"11","author":"Ning","year":"2022","journal-title":"Food Sci. Hum. Well"},{"key":"B24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(11)60614-4","article-title":"Type 2 diabetes across generations: from pathophysiology to prevention and management","volume":"378","author":"Nolan","year":"2011","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100188","DOI":"10.1016\/j.carpta.2022.100188","article-title":"A review on potential anti-diabetic mechanisms of chitosan and its derivatives","volume":"3","author":"Priyanka","year":"2022","journal-title":"Carbohyd Polym."},{"key":"B26","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.molcel.2015.05.004","article-title":"High-throughput sequencing technologies","volume":"58","author":"Reuter","year":"2015","journal-title":"Mol. Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"154177","DOI":"10.1016\/j.phymed.2022.154177","article-title":"Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology","volume":"102","author":"Shao","year":"2022","journal-title":"Phytomedicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"172526","DOI":"10.1016\/j.ejphar.2019.172526","article-title":"Antidiabetic effects of pterostilbene through PI3K\/Akt signal pathway in high fat diet and STZ-induced diabetic rats","volume":"859","author":"Sun","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"153107","DOI":"10.1016\/j.phymed.2019.153107","article-title":"Effect of gomisin A on osteoblast differentiation in high glucose-mediated oxidative stress","volume":"66","author":"Takanche","year":"2020","journal-title":"Phytomedicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jep.2017.05.021","article-title":"Chinese materia medica used in medicinal diets","volume":"206","author":"Tan","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"154961","DOI":"10.1016\/j.metabol.2021.154961","article-title":"The clustering of cardiovascular, renal, adipo-metabolic eye and liver disease with type 2 diabetes","volume":"128","author":"Thomas","year":"2022","journal-title":"Metabolism"},{"key":"B32","doi-asserted-by":"publisher","first-page":"153600","DOI":"10.1016\/j.phymed.2021.153600","article-title":"The antidepressant-like effects of Danggui Buxue Decoction in GK rats by activating CREB\/BDNF\/TrkB signaling pathway","volume":"89","author":"Wang","year":"","journal-title":"Phytomedicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1875-5364(21)60001-8","article-title":"TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches","volume":"19","author":"Wang","year":"","journal-title":"Chin. J. Nat. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"112771","DOI":"10.1016\/j.biopha.2022.112771","article-title":"Recent update on application of dihydromyricetin in metabolic related diseases","volume":"148","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S2095-4964(16)60255-8","article-title":"Need of integrated dietary therapy for persons with diabetes mellitus and \u201cunhealthy\u201d body constitution presentations","volume":"14","author":"Wong","year":"2016","journal-title":"Chin. J. Integr. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"154268","DOI":"10.1016\/j.phymed.2022.154268","article-title":"Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine","volume":"104","author":"Yang","year":"","journal-title":"Phytomedicine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"153810","DOI":"10.1016\/j.phymed.2021.153810","article-title":"Gegen Qinlian Decoction ameliorates type 2 diabetes osteoporosis via IGFBP3\/MAPK\/NFATc1 signaling pathway based on cytokine antibody array","volume":"94","author":"Yang","year":"","journal-title":"Phytomedicine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.wjam.2021.11.008","article-title":"Impacts of electroacupuncture at auricular concha on gastrointestinal motility in the rats with type 2 diabetes","volume":"32","author":"Yang","year":"","journal-title":"World J. Acupunct. - Moxibustion"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.bbrc.2016.11.164","article-title":"Protective effects of gomisin N against hepatic steatosis through AMPK activation","volume":"482","author":"Yun","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"104544","DOI":"10.1016\/j.yrtph.2019.104544","article-title":"Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: dual regulation of the PI3K\/AKT and MAPK pathways","volume":"110","author":"Zhang","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"114051","DOI":"10.1016\/j.jep.2021.114051","article-title":"Chemical profile of Swertia mussotii Franch and its potential targets against liver fibrosis revealed by cross-platform metabolomics","volume":"274","author":"Zhang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"153455","DOI":"10.1016\/j.phymed.2020.153455","article-title":"Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"88","author":"Zheng","year":"2021","journal-title":"Phytomedicine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"113984","DOI":"10.1016\/j.jpba.2021.113984","article-title":"Comparative analysis of chemical components in different parts of Epimedium Herb","volume":"198","author":"Zhou","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"B44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.freeradbiomed.2009.10.040","article-title":"Puerarin attenuates high-glucose-and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2\/Rac1-dependent signaling","volume":"48","author":"Zhu","year":"2010","journal-title":"Free Radic. Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1282077\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T10:05:05Z","timestamp":1700301905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1282077\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":44,"alternative-id":["10.3389\/fphar.2023.1282077"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1282077","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]},"article-number":"1282077"}}